United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	24,128	21,265	15,818	10,344	12,801	9,741
Market Cap Growth	73.67%	34.43%	52.93%	-19.20%	31.41%	44.27%
Enterprise Value	20,657	18,345	12,851	8,050	10,762	8,610
Last Close Price	568.43	487.25	352.84	219.89	278.09	216.08
PE Ratio	21.00	17.49	14.32	11.10	18.54	21.48
Forward PE	19.95	17.14	12.17	9.93	13.57	13.45
PEG Ratio	2.05	4.43	1.02	13.47	0.74	0.74
PS Ratio	7.61	6.68	5.50	4.44	6.61	5.78
PB Ratio	4.06	3.00	2.45	1.73	2.67	2.46
P/TBV Ratio	4.58	3.29	2.66	1.83	2.81	2.58
P/FCF Ratio	23.73	20.43	14.64	13.84	19.29	20.40
P/OCF Ratio	15.43	13.62	11.92	10.58	15.95	16.28
EV/Sales Ratio	6.52	5.76	4.47	3.46	5.56	5.11
EV/EBITDA Ratio	13.34	11.62	8.87	6.50	10.44	14.21
EV/EBIT Ratio	14.15	12.29	9.33	6.79	10.99	15.49
EV/FCF Ratio	20.31	17.63	11.89	10.77	16.22	18.04
Debt / Equity Ratio	-	0	0.05	0.12	0.17	0.20
Debt / EBITDA Ratio	-	-	0.21	0.56	0.78	1.32
Debt / FCF Ratio	-	-	0.28	0.94	1.21	1.68
Net Debt / Equity Ratio	-0.36	-0.41	-0.46	-0.38	-0.42	-0.29
Net Debt / EBITDA Ratio	-1.41	-1.85	-2.05	-1.85	-1.98	-1.87
Net Debt / FCF Ratio	-2.12	-2.81	-2.75	-3.07	-3.07	-2.37
Asset Turnover	0.43	0.42	0.40	0.35	0.35	0.34
Inventory Turnover	2.35	2.25	2.30	2.41	1.55	1.36
Quick Ratio	4.12	5.83	4.80	4.07	8.91	6.97
Current Ratio	4.79	6.60	5.25	4.41	9.85	7.61
Return on Equity (ROE)	19.81%	19.71%	19.23%	18.27%	16.61%	12.94%
Return on Assets (ROA)	15.74%	15.25%	14.72%	13.86%	13.37%	9.10%
Return on Invested Capital (ROIC)	26.92%	28.27%	28.04%	26.73%	24.82%	15.75%
Return on Capital Employed (ROCE)	21.37%	21.41%	21.20%	19.64%	18.55%	12.14%
Earnings Yield	5.34%	5.72%	6.98%	9.01%	5.39%	4.66%
FCF Yield	4.21%	4.89%	6.83%	7.23%	5.18%	4.90%
Buyback Yield / Dilution	1.40%	1.24%	2.41%	-2.47%	-2.54%	-6.05%
Total Shareholder Return	1.40%	1.24%	2.41%	-2.47%	-2.54%	-6.05%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q